Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells
BACKGROUND AND OBJECTIVE: C-Myc plays a very important role in controlling cell proliferation, apoptosis and differentiation. Due to the involvement of c-Myc in the regulation of a wide range of intracellular functions and based on its role in the pathogenesis of acute promyelocytic leukemia (APL),...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/413408a6ed424f8989e2130e9548a702 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:413408a6ed424f8989e2130e9548a702 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:413408a6ed424f8989e2130e9548a7022021-11-29T07:40:49ZCytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells1561-41072251-7170https://doaj.org/article/413408a6ed424f8989e2130e9548a7022021-03-01T00:00:00Zhttp://jbums.org/article-1-9093-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: C-Myc plays a very important role in controlling cell proliferation, apoptosis and differentiation. Due to the involvement of c-Myc in the regulation of a wide range of intracellular functions and based on its role in the pathogenesis of acute promyelocytic leukemia (APL), the present study was conducted to investigate the anti-leukemia effect of 10058-F4, as a known c-Myc inhibitor, on APL-derived HL-60 cells. METHODS: In this experimental study, to evaluate the cytotoxic effects of 10058-F4 in acute promyelocytic leukemia, HL-60 cell line (prepared from Pasteur Institute of Iran) was treated with different doses of inhibitor (50, 100, 150 and 200 μM) and then in 24 -and 36- hours intervals, survival rate, cell count, metabolic activity and induction of apoptosis were respectively evaluated. In addition, transcriptional changes of apoptosis-related genes were studied by real-time PCR to investigate the molecular mechanisms of function of 10058-F4. FINDINGS: The results showed that inhibition of c-Myc by 10058-F4 at doses of 150 and 200 μM in 24 hours reduced the growth of HL-60 cells by 38±4% and 49±3.2%, respectively, compared to the control group (p<0.05). In addition, the cytotoxic effects of the drug are due to the arrest of cells in the G1 phase and the induction of apoptosis; Because the percentage of cells stained with Annexin V/PI in cells treated at a dose of 100 μM after 24 hours increased by 31% compared to the control group (p<0.05). CONCLUSION: In this study, the efficacy of 10058-F4 in HL-60 cells was fully established.M SayyadiA Safaroghli-AzarD BashashBabol University of Medical Sciencesarticleacute promyelocytic leukemiac-myc10058-f4hl-60 cell line.MedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 23, Iss 1, Pp 150-157 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN FA |
topic |
acute promyelocytic leukemia c-myc 10058-f4 hl-60 cell line. Medicine R Medicine (General) R5-920 |
spellingShingle |
acute promyelocytic leukemia c-myc 10058-f4 hl-60 cell line. Medicine R Medicine (General) R5-920 M Sayyadi A Safaroghli-Azar D Bashash Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells |
description |
BACKGROUND AND OBJECTIVE: C-Myc plays a very important role in controlling cell proliferation, apoptosis and differentiation. Due to the involvement of c-Myc in the regulation of a wide range of intracellular functions and based on its role in the pathogenesis of acute promyelocytic leukemia (APL), the present study was conducted to investigate the anti-leukemia effect of 10058-F4, as a known c-Myc inhibitor, on APL-derived HL-60 cells.
METHODS: In this experimental study, to evaluate the cytotoxic effects of 10058-F4 in acute promyelocytic leukemia, HL-60 cell line (prepared from Pasteur Institute of Iran) was treated with different doses of inhibitor (50, 100, 150 and 200 μM) and then in 24 -and 36- hours intervals, survival rate, cell count, metabolic activity and induction of apoptosis were respectively evaluated. In addition, transcriptional changes of apoptosis-related genes were studied by real-time PCR to investigate the molecular mechanisms of function of 10058-F4.
FINDINGS: The results showed that inhibition of c-Myc by 10058-F4 at doses of 150 and 200 μM in 24 hours reduced the growth of HL-60 cells by 38±4% and 49±3.2%, respectively, compared to the control group (p<0.05). In addition, the cytotoxic effects of the drug are due to the arrest of cells in the G1 phase and the induction of apoptosis; Because the percentage of cells stained with Annexin V/PI in cells treated at a dose of 100 μM after 24 hours increased by 31% compared to the control group (p<0.05).
CONCLUSION: In this study, the efficacy of 10058-F4 in HL-60 cells was fully established. |
format |
article |
author |
M Sayyadi A Safaroghli-Azar D Bashash |
author_facet |
M Sayyadi A Safaroghli-Azar D Bashash |
author_sort |
M Sayyadi |
title |
Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells |
title_short |
Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells |
title_full |
Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells |
title_fullStr |
Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells |
title_full_unstemmed |
Cytotoxic and Apoptotic Effects of C-Myc Inhibition by 10058-F4 on Acute Promyelocytic Leukemia Cells |
title_sort |
cytotoxic and apoptotic effects of c-myc inhibition by 10058-f4 on acute promyelocytic leukemia cells |
publisher |
Babol University of Medical Sciences |
publishDate |
2021 |
url |
https://doaj.org/article/413408a6ed424f8989e2130e9548a702 |
work_keys_str_mv |
AT msayyadi cytotoxicandapoptoticeffectsofcmycinhibitionby10058f4onacutepromyelocyticleukemiacells AT asafaroghliazar cytotoxicandapoptoticeffectsofcmycinhibitionby10058f4onacutepromyelocyticleukemiacells AT dbashash cytotoxicandapoptoticeffectsofcmycinhibitionby10058f4onacutepromyelocyticleukemiacells |
_version_ |
1718407520399130624 |